Literature DB >> 2955518

Islet allograft survival after a single course of treatment of recipient with antibody to L3T4.

J A Shizuru, A K Gregory, C T Chao, C G Fathman.   

Abstract

Allografts of pancreatic islets of Langerhans were induced to survive for an indefinite period in diabetic mice if, at the time of engraftment, the mice received a single course of treatment with a monoclonal antibody directed against the L3T4 determinant, a nonpolymorphic cell surface glycoprotein present on the cell surface of the murine T helper-inducer lymphocyte subset. This treatment allowed the survival of islets of Langerhans transplanted across a major histocompatibility barrier without additional immunosuppression. The results demonstrate that the lymphocyte subset defined by the expression of the L3T4 molecules is central to the induction of allograft rejection and provides a model for tolerance induction for organ allograft transplantation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2955518     DOI: 10.1126/science.2955518

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  26 in total

1.  CD4(+) Valpha14 natural killer T cells are essential for acceptance of rat islet xenografts in mice.

Authors:  Y Ikehara; Y Yasunami; S Kodama; T Maki; M Nakano; T Nakayama; M Taniguchi; S Ikeda
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

Review 2.  Allograft rejection results from a failed attempt by the immune system to protect foreign tissue.

Authors:  D S Hall; E Roberts; J Davies
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

Review 3.  Regulation of immunity by anti-T-cell antibodies.

Authors:  D Wofsy
Journal:  West J Med       Date:  1990-09

4.  CD4+ T lymphocytes are not necessary for the acute rejection of vascularized mouse lung transplants.

Authors:  Andrew E Gelman; Mikio Okazaki; Jiaming Lai; Christopher G Kornfeld; Friederike H Kreisel; Steven B Richardson; Seiichiro Sugimoto; Jeremy R Tietjens; G Alexander Patterson; Alexander S Krupnick; Daniel Kreisel
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

Review 5.  Premises for immune interventional therapy in rheumatoid arthritis.

Authors:  I R Mackay; M J Rowley
Journal:  Postgrad Med J       Date:  1988-07       Impact factor: 2.401

6.  Low energy X-ray (grenz ray) treatment of purified islets prior to allotransplant markedly decreases passenger leukocyte populations.

Authors:  Rena Pawlick; Boris Gala-Lopez; Andrew R Pepper; Nasser Abualhassan; Antonio Bruni; Kunimasa Suzuki; Gina Rayat; John F Elliott; A M James Shapiro
Journal:  Islets       Date:  2017-07-10       Impact factor: 2.694

7.  The effect of anti-CD4 on helper function of CD4,45RA+ versus CD4,45RO+ T cells.

Authors:  J Wang; T Yan; B Simmer; F Emmrich
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

Review 8.  Pancreatic islet xenotransplantation: barriers and prospects.

Authors:  Gina R Rayat; Ronald G Gill
Journal:  Curr Diab Rep       Date:  2003-08       Impact factor: 4.810

9.  Rat pancreatic islet pretreatment with anti-MHC class II monoclonal antibodies and culture: in vitro MLIC test response does not predict islet allograft survival.

Authors:  R G Bretzel; B K Flesch; G Brennenstuhl; I Greiner; B J Hering; M Woehrle; K Federlin
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

10.  Direct evidence for clonal destruction of allo-reactive T cells in the mice treated with cyclophosphamide after allo-priming.

Authors:  T Maeda; M Eto; Y Nishimura; K Nomoto; Y Y Kong; K Nomoto
Journal:  Immunology       Date:  1993-01       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.